Overall Survival With Maintenance Olaparib at a 7-Year Follow-up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial : Obstetrical & Gynecological Survey

Journal Logo

GYNECOLOGY: GYNECOLOGIC ONCOLOGY

Overall Survival With Maintenance Olaparib at a 7-Year Follow-up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

DiSilvestro, Paul; Banerjee, Susana; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S.; Gourley, Charlie; Oza, Amit; González-Martín, Antonio; Aghajanian, Carol; Bradley, William; Mathews, Cara; Liu, Joyce; McNamara, John; Lowe, Elizabeth S.; Ah-See, Mei-Lin; Moore, Kathleen N. on behalf of the SOLO1 Investigators

Author Information
Obstetrical & Gynecological Survey 78(1):p 25-27, January 2023. | DOI: 10.1097/OGX.0000000000001120

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid